<\/p>\n
\n OSE is an independent investment company and venture builder partnered with the University of Oxford that transforms academic research into commercial spinout businesses.\n<\/p>\n
\n Dr Moore brings more than 20 years of biotech venture capital experience spanning North America and Europe.\n<\/p>\n
\n He recently served as president of Boston-based MP Healthcare Venture Management, where he led strategic early-stage investments from scientific discovery through to exit.\n<\/p>\n
\n His track record includes backing university spinouts before formal fundraising rounds, including Covagen, which was acquired by Johnson & Johnson, and Trimtech Therapeutics, a Cambridge-based company that raised \u00a336 million in June 2026.\n<\/p>\n
\n Jack Edmondson, chief investment officer at OSE, said: “Jeff is one of those rare investors who looks beyond the pitch deck to evaluate the underlying science.\n<\/p>\n
\n “His deep roots in North American venture capital, combined with a willingness to back early, high-risk academic discoveries, make him ideal for this role.\n<\/p>\n
\n “As Oxford continues to generate world-class spinouts, we\u2019re delighted to have Jeff\u2019s global expertise and leadership in Life Sciences at OSE.\n<\/p>\n
\n “I also want to extend my thanks to Katya for her exceptional leadership in driving our Life Sciences portfolio forward, and I am delighted we will continue to benefit from her expertise as Advisor.”\n<\/p>\n
\n Dr Moore, who holds a DPhil from Oxford and an MBA from the Massachusetts Institute of Technology, described the appointment as a ‘full-circle moment’.\n<\/p>\n
\n He said: “Returning to Oxford, where I completed my PhD, feels like a full-circle moment.\n<\/p>\n
\n “My passion has always been identifying ground-breaking academic science early and partnering with founders to translate those discoveries into commercial entities that transform patients\u2019 lives.\n<\/p>\n
\n “Oxford is unmatched in its potential for breakthrough platform technologies and novel therapeutic modalities.\n<\/p>\n
\n “I look forward to partnering with exceptional founders and building strong bridges between Oxford’s spinout pipeline and global co-investors.”\n<\/p>\n
\n OSE, which finds, funds, and builds transformational companies from the University of Oxford\u2019s world-leading research, focuses on Life Sciences, Health Tech, and Deep Tech.\n<\/p>\n
\n Dr Moore joins the organisation at a time of ‘strong momentum’ within its life sciences portfolio, following the recent acquisition of OSE-backed Dark Blue Therapeutics by Amgen in a deal worth up to $840 million.\n<\/p>\n
\n He succeeds Katya Smirnyagina, who guided the Life Sciences team and portfolio through significant growth over the past five years and will continue with OSE as an Advisor.\n<\/p>\n
\n During her tenure, Ms Smirnyagina oversaw significant growth across the portfolio.\n<\/p>\n
#Oxford #Science #Enterprises #appoints #life #sciences<\/p>\n","protected":false},"excerpt":{"rendered":"
OSE is an independent investment company and venture builder partnered with the University of Oxford that transforms academic research into commercial spinout businesses. Dr Moore brings more than 20 years… <\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[2],"tags":[],"class_list":["post-1480","post","type-post","status-publish","format-standard","hentry","category-finance-news"],"_links":{"self":[{"href":"https:\/\/stock789.top\/index.php?rest_route=\/wp\/v2\/posts\/1480","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/stock789.top\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/stock789.top\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/stock789.top\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/stock789.top\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=1480"}],"version-history":[{"count":0,"href":"https:\/\/stock789.top\/index.php?rest_route=\/wp\/v2\/posts\/1480\/revisions"}],"wp:attachment":[{"href":"https:\/\/stock789.top\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=1480"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/stock789.top\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=1480"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/stock789.top\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=1480"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}